Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus-Reference-Cited by-同舟云学术

Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus

Published:2018-01 Issue:1 Volume:51 Page:38-42
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Wouthuyzen-Bakker Marjan,Tornero Eduard,Morata Laura,Nannan Panday Prashant V.,Jutte Paul C.,Bori Guillem,Kampinga Greetje A.,Soriano Alex

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference25 articles.

1. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign body infection (FBI) study group;Zimmerli;JAMA,1998

2. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus;Senneville;Clin Infect Dis,2011

3. A large multicenter study of methicillin susceptible and methicillin resistant Staphylococcus aureus prosthetic joint infections managed with implant retention;Lora-Tamayo;Clin Infect Dis,2013

4. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America;Osmon;Clin Infect Dis,2013

5. Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation;Landersdorfer;Antimicrob Agents Chemother,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Therapy in One-Stage Revision Surgery;One-Stage Septic Revision Arthroplasty;2024

2. Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives;Microorganisms;2023-12-18

3. Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach;Expert Opinion on Drug Metabolism & Toxicology;2023-08-03

4. Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections;International Journal of Antimicrobial Agents;2023-08

5. Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?;Expert Review of Anti-infective Therapy;2023-05-08